Stock listing

Rhythm Biosciences Limited

Selected listing: RHY · ASX · AUD · AU

Rhythm Biosciences Limited (ASX:RHY), Health Technology. Latest release Oct 6, 2026: ColoSTAT Economic Study - Australian Public Health Savings.

RHY:ASXAUDAUUpdated September 25, 2026
Rhythm Biosciences Limited logo
Ticker
ASX:RHY
Asset type
Stock
Sector
Health Technology
Industry
Medical Specialties
Exchange
ASX
Currency
AUD

About Rhythm Biosciences Limited

The company focuses on developing innovative diagnostic solutions. Rhythm Biosciences aims to improve healthcare outcomes through its research and product offerings.

Latest news from Rhythm Biosciences Limited

ColoSTAT Economic Study - Australian Public Health Savings

October 6, 2026

Initial ColoSTAT Assessment in UK opens new market access

September 21, 2026

FY26 Appendix 4E & Audited Financial Report

August 27, 2026

Response to ASX Query Letter

April 14, 2026

First ColoSTAT Clinical Test Sale

March 10, 2026

All Rhythm Biosciences Limited news →

Research Rhythm Biosciences Limited

Rhythm Biosciences Limited company profile

View the public company page for Rhythm Biosciences Limited on 6ix.

Rhythm Biosciences Limited news

Read company news and market updates connected to Rhythm Biosciences Limited.

Rhythm Biosciences Limited investor events

Find investor webinars, events, and replay context for Rhythm Biosciences Limited.

Alternate listings

0RY:FWB

DE · EUR

Alternate listing for Rhythm Biosciences Limited; the primary context on this page is RHY:ASX.